Rui Daniel Prediger
Overview
Explore the profile of Rui Daniel Prediger including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
65
Citations
686
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Somensi N, Cristiane Lopes S, Gasparotto J, Mayer Goncalves R, Tiefensee-Ribeiro C, Peixoto D, et al.
Neurochem Int
. 2021 Oct;
151:105215.
PMID: 34710535
Parkinson's disease (PD) is a neurodegenerative disease characterized by progressive loss of the nigrostriatal dopaminergic neurons that are associated with motor alterations and non-motor manifestations (such as depression). Neuroinflammation is...
12.
da Luz Scheffer D, Freitas F, Aguiar Jr A, Ward C, Guglielmo L, Prediger R, et al.
Brain Commun
. 2021 Aug;
3(3):fcab116.
PMID: 34423297
Fatigue is a common symptom of Parkinson's disease that compromises significantly the patients' quality of life. Despite that, fatigue has been under-recognized as symptom, its pathophysiology remains poorly understood, and...
13.
de Carvalho C, Lopes M, Constantino L, Hoeller A, de Melo H, Guarnieri R, et al.
Mol Psychiatry
. 2021 Jul;
26(12):7257-7269.
PMID: 34316004
We demonstrate that the rate of extracellular signal-related kinase phosphorylation (P-ERK1,2/Total-ERK1,2) in the amygdala is negatively and independently associated with anxiety symptoms in 23 consecutive patients with drug-resistant mesial temporal...
14.
Agnes J, Santos V, das Neves R, Mayer Goncalves R, Delgobo M, Girardi C, et al.
J Pain
. 2021 Mar;
22(8):996-1013.
PMID: 33774154
Chemotherapy-Induced Peripheral Neuropathy (CIPN) is a common, difficult-to-treat, and dose-limiting side effect associated with Oxaliplatin (OXA) treatment. In this study, we evaluated the effect of three antioxidants - namely N-acetylcysteine,...
15.
Braga S, Delanogare E, Machado A, Prediger R, Moreira E
Behav Brain Res
. 2020 Oct;
398:112969.
PMID: 33075395
Obesity represents a risk factor for metabolic syndrome and cardiovascular and psychiatric disorders. Excessive caloric intake, particularly in dietary fats, is an environmental factor that contributes to obesity development. Thus,...
16.
Dos Santos B, Schmitz A, Lopes de Almeida G, de Souza L, Szczepanik J, Nunes E, et al.
Neurochem Res
. 2020 Sep;
45(12):2868-2883.
PMID: 32968860
Recent evidence suggests that young rodents submitted to high fructose (FRU) diet develop metabolic, and cognitive dysfunctions. However, it remains unclear whether these detrimental effects of FRU intake can also...
17.
Falchetti M, Prediger R, Zanotto-Filho A
Comput Biol Med
. 2020 Sep;
124:103925.
PMID: 32889300
Diagnosis of Parkinson's disease (PD) remains a challenge in clinical practice, mostly due to lack of peripheral blood markers. Transcriptomic analysis of blood samples has emerged as a potential means...
18.
Mack J, de Menezes Moura T, Bobinski F, Martins D, Cunha R, Walz R, et al.
Neurotoxicology
. 2020 Aug;
80:144-154.
PMID: 32738267
Exposure to fungicide ziram (zinc dimethyldithiocarbamate) has been associated with increased incidence of Parkinson's disease (PD). We recently demonstrated that the intranasal (i.n.) administration of sodium dimethyldithiocarbamate (NaDMDC, a more...
19.
Sampaio T, Marques N, Binder L, Tasca C, Prediger R
Oxid Med Cell Longev
. 2020 Aug;
2020:8324565.
PMID: 32733637
Degeneration of the (LC), the main source of cerebral noradrenaline (NA), has been reported in diverse neurodegenerative diseases, including Parkinson's diseases (PD). There is increasing evidence indicating the role of...
20.
Franca A, Schamne M, de Souza B, da Luz Scheffer D, Bernardelli A, Correa T, et al.
Mol Neurobiol
. 2020 Jul;
57(9):3902-3919.
PMID: 32621279
Attention deficit hyperactivity disorder (ADHD) is a prevalent and disabling disorder, mainly characterized by hyperactivity, inattention, and impulsivity, but also by olfactory and memory impairments that frequently persist throughout lifetime....